These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 35066875)

  • 1. Single Cell Genetic Profiling of Tumors of Breast Cancer Patients Aged 50 Years and Older Reveals Enormous Intratumor Heterogeneity Independent of Individual Prognosis.
    Liegmann AS; Heselmeyer-Haddad K; Lischka A; Hirsch D; Chen WD; Torres I; Gemoll T; Rody A; Thorns C; Gertz EM; Alkemade H; Hu Y; Habermann JK; Ried T
    Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34282768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma.
    Kinnaman MD; Zaccaria S; Makohon-Moore A; Arnold B; Levine MF; Gundem G; Arango Ossa JE; Glodzik D; Rodríguez-Sánchez MI; Bouvier N; Li S; Stockfisch E; Dunigan M; Cobbs C; Bhanot UK; You D; Mullen K; Melchor JP; Ortiz MV; O'Donohue TJ; Slotkin EK; Wexler LH; Dela Cruz FS; Hameed MR; Glade Bender JL; Tap WD; Meyers PA; Papaemmanuil E; Kung AL; Iacobuzio-Donahue CA
    Cancer Res; 2023 Nov; 83(22):3796-3812. PubMed ID: 37812025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in Pathology: the 2022 Annual Review Issue of The Journal of Pathology.
    Herrington CS; Poulsom R; Pillay N; Bankhead P; Coates PJ
    J Pathol; 2022 Jul; 257(4):379-382. PubMed ID: 35635736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refining tumor-associated aneuploidy through 'genomic recoding' of recurrent DNA copy number aberrations in 150 canine non-Hodgkin lymphomas.
    Thomas R; Seiser EL; Motsinger-Reif A; Borst L; Valli VE; Kelley K; Suter SE; Argyle D; Burgess K; Bell J; Lindblad-Toh K; Modiano JF; Breen M
    Leuk Lymphoma; 2011 Jul; 52(7):1321-35. PubMed ID: 21375435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic identification of mutations and copy number alterations associated with cancer patient prognosis.
    Smith JC; Sheltzer JM
    Elife; 2018 Dec; 7():. PubMed ID: 30526857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor evolution metrics predict recurrence beyond 10 years in locally advanced prostate cancer.
    Fernandez-Mateos J; Cresswell GD; Trahearn N; Webb K; Sakr C; Lampis A; Stuttle C; Corbishley CM; Stavrinides V; Zapata L; Spiteri I; Heide T; Gallagher L; James C; Ramazzotti D; Gao A; Kote-Jarai Z; Acar A; Truelove L; Proszek P; Murray J; Reid A; Wilkins A; Hubank M; Eeles R; Dearnaley D; Sottoriva A
    Nat Cancer; 2024 Jul; ():. PubMed ID: 38997466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional ex vivo DNA fibre assay to measure replication dynamics in breast cancer tissue.
    Chen M; van den Tempel N; Bhattacharya A; Yu S; Rutgers B; Fehrmann RS; de Haas S; van der Vegt B; van Vugt MA
    J Pathol; 2024 Jul; ():. PubMed ID: 39022850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into the Clinical, Biological and Therapeutic Impact of Copy Number Alteration in Cancer.
    Carey-Smith SL; Kotecha RS; Cheung LC; Malinge S
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 38999925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HATCHet2: clone- and haplotype-specific copy number inference from bulk tumor sequencing data.
    Myers MA; Arnold BJ; Bansal V; Mullen KM; Zaccaria S; Raphael BJ
    bioRxiv; 2023 Jul; ():. PubMed ID: 37502835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CINner: modeling and simulation of chromosomal instability in cancer at single-cell resolution.
    Dinh KN; Vázquez-García I; Chan A; Malhotra R; Weiner A; McPherson AW; Tavaré S
    bioRxiv; 2024 Apr; ():. PubMed ID: 38617259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual Intratumor Heterogeneity and Breast Tumor Progression.
    Li Y; Van Alsten SC; Lee DN; Kim T; Calhoun BC; Perou CM; Wobker SE; Marron JS; Hoadley KA; Troester MA
    Cancers (Basel); 2024 Jun; 16(13):. PubMed ID: 39001357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour break load is a biologically relevant feature of genomic instability with prognostic value in colorectal cancer.
    Lakbir S; Lahoz S; Cuatrecasas M; Camps J; Glas RA; Heringa J; Meijer GA; Abeln S; Fijneman RJA
    Eur J Cancer; 2022 Dec; 177():94-102. PubMed ID: 36334560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refphase: Multi-sample phasing reveals haplotype-specific copy number heterogeneity.
    Watkins TBK; Colliver EC; Huska MR; Kaufmann TL; Lim EL; Duncan CB; Haase K; Van Loo P; Swanton C; McGranahan N; Schwarz RF
    PLoS Comput Biol; 2023 Oct; 19(10):e1011379. PubMed ID: 37871126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel 9-gene signature for the prediction of postoperative recurrence in stage II/III colorectal cancer.
    Xin C; Lai Y; Ji L; Wang Y; Li S; Hao L; Zhang W; Meng R; Xu J; Hong Y; Lou Z
    Front Genet; 2022; 13():1097234. PubMed ID: 36704343
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic and microenvironmental intra-tumor heterogeneity impacts colorectal cancer evolution and metastatic development.
    Sobral D; Martins M; Kaplan S; Golkaram M; Salmans M; Khan N; Vijayaraghavan R; Casimiro S; Fernandes A; Borralho P; Ferreira C; Pinto R; Abreu C; Costa AL; Zhang S; Pawlowski T; Godsey J; Mansinho A; Macedo D; Lobo-Martins S; Filipe P; Esteves R; Coutinho J; Costa PM; Ramires A; Aldeia F; Quintela A; So A; Liu L; Grosso AR; Costa L
    Commun Biol; 2022 Sep; 5(1):937. PubMed ID: 36085309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic pathway-based molecular subtyping of colon cancer reveals clinical immunotherapy potential and prognosis.
    Dai Z; Peng X; Guo Y; Shen X; Ding W; Fu J; Liang Z; Song J
    J Cancer Res Clin Oncol; 2023 Jun; 149(6):2393-2416. PubMed ID: 35731273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copy-number intratumor heterogeneity increases the risk of relapse in chemotherapy-naive stage II colon cancer.
    Lahoz S; Archilla I; Asensio E; Hernández-Illán E; Ferrer Q; López-Prades S; Nadeu F; Del Rey J; Sanz-Pamplona R; Lozano JJ; Castells A; Cuatrecasas M; Camps J
    J Pathol; 2022 May; 257(1):68-81. PubMed ID: 35066875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copy-number intratumor heterogeneity as high-risk feature of stage II colon cancer
    van den Bosch T; Miedema DM; Vermeulen L
    J Pathol; 2022 Aug; 257(5):575-578. PubMed ID: 35470895
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.